Cambridge Investment Research Advisors’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Buy |
121,315
+2,730
| +2% | +$5.76K | ﹤0.01% | 3113 |
|
|
2025
Q1 | $145K | Hold |
118,585
| – | – | ﹤0.01% | 3280 |
|
|
2024
Q4 | $153K | Buy |
118,585
+3,865
| +3% | +$4.99K | ﹤0.01% | 3248 |
|
|
2024
Q3 | $315K | Buy |
114,720
+2,590
| +2% | +$7.11K | ﹤0.01% | 2796 |
|
|
2024
Q2 | $253K | Sell |
112,130
-9,011
| -7% | -$20.3K | ﹤0.01% | 2839 |
|
|
2024
Q1 | $290K | Sell |
121,141
-5,440
| -4% | -$13K | ﹤0.01% | 2725 |
|
|
2023
Q4 | $210K | Sell |
126,581
-11,591
| -8% | -$19.2K | ﹤0.01% | 2860 |
|
|
2023
Q3 | $265K | Buy |
138,172
+3,840
| +3% | +$7.37K | ﹤0.01% | 2587 |
|
|
2023
Q2 | $193K | Sell |
134,332
-8,071
| -6% | -$11.6K | ﹤0.01% | 2891 |
|
|
2023
Q1 | $299K | Sell |
142,403
-9,168
| -6% | -$19.3K | ﹤0.01% | 2494 |
|
|
2022
Q4 | $171K | Buy |
151,571
+910
| +0.6% | +$1.03K | ﹤0.01% | 2799 |
|
|
2022
Q3 | $246K | Buy |
150,661
+1,922
| +1% | +$3.14K | ﹤0.01% | 2532 |
|
|
2022
Q2 | $195K | Buy |
148,739
+3,532
| +2% | +$4.63K | ﹤0.01% | 2725 |
|
|
2022
Q1 | $234K | Sell |
145,207
-7,820
| -5% | -$12.6K | ﹤0.01% | 2753 |
|
|
2021
Q4 | $317K | Sell |
153,027
-11,471
| -7% | -$23.8K | ﹤0.01% | 2483 |
|
|
2021
Q3 | $638K | Sell |
164,498
-3,818
| -2% | -$14.8K | ﹤0.01% | 1858 |
|
|
2021
Q2 | $539K | Buy |
+168,316
| New | +$539K | ﹤0.01% | 1989 |
|
|
2021
Q1 | – | Sell |
-179,556
| Closed | -$402K | – | 2916 |
|
|
2020
Q4 | $402K | Sell |
179,556
-11,639
| -6% | -$26.1K | ﹤0.01% | 1920 |
|
|
2020
Q3 | $510K | Sell |
191,195
-11,732
| -6% | -$31.3K | ﹤0.01% | 1588 |
|
|
2020
Q2 | $621K | Sell |
202,927
-1,897
| -0.9% | -$5.81K | ﹤0.01% | 1428 |
|
|
2020
Q1 | $401K | Buy |
204,824
+14,144
| +7% | +$27.7K | ﹤0.01% | 1507 |
|
|
2019
Q4 | $545K | Sell |
190,680
-42,964
| -18% | -$123K | ﹤0.01% | 1528 |
|
|
2019
Q3 | $857K | Buy |
233,644
+1,090
| +0.5% | +$4K | 0.01% | 1159 |
|
|
2019
Q2 | $965K | Buy |
232,554
+56,332
| +32% | +$234K | 0.01% | 1038 |
|
|
2019
Q1 | $900K | Buy |
+176,222
| New | +$900K | 0.01% | 1095 |
|